Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESIGN study of dietary sodium intake and ertugliflozin effects in adults with type 2 diabetes
NL-OMON53765Phase 4Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ertugliflozin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Vrije University Medical Center. Started Jul 2023; status: recruiting.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON53765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53765.